COMMUNIQUÉS West-GlobeNewswire

-
Medicare Now Reimbursing for EnteroTrack’s Esophageal String Test®, Expanding Access to Patients with Eosinophilic Esophagitis
08/10/2025 -
Channel Medsystems Appoints Healthcare Executive Skip Baldino to Board of Directors
08/10/2025 -
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
08/10/2025 -
Tessera Therapeutics Awarded up to $41.3 Million from ARPA-H to Advance In Vivo CAR-T Therapies
08/10/2025 -
Protext Mobility, Inc. (OTC: TXTM) Announces New Member of Its Advisory Board
08/10/2025 -
Unyte Health Celebrates 10 Years as the Leader in Nervous System Regulation and Sound-Based Listening Therapies
08/10/2025 -
Turn Therapeutics to Commence Trading Today on Nasdaq
08/10/2025 -
Ashvattha Therapeutics to Present Phase 2 DME and nAMD Data at Innovate Retina
08/10/2025 -
ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy® (epinephrine nasal spray)
08/10/2025 -
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer
08/10/2025 -
MAPS and HoloMind Institute Host International MDMA-Assisted Therapy Training in Poland
08/10/2025 -
Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT
08/10/2025 -
Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025
08/10/2025 -
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/10/2025 -
Starton Therapeutics to Share Innovative Lenalidomide Delivery Technology on Labroots Webinar Sponsored by Primetech Corporation
08/10/2025 -
Nasus Pharma Announces Expanded Agreement to Support Development and Commercialization of NS002 Intranasal Epinephrine Program
08/10/2025 -
Prenetics’ IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging
08/10/2025 -
MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025
08/10/2025 -
Evaxion expands AI-Immunology™ platform with automated vaccine design module
08/10/2025
Pages